Alhemo

Active Ingredient(s): Concizumab-mtci
FDA Approved: * December 20, 2024
Pharm Company: * NOVO NORDISK INC
Category: Blood Clotting (Hemostasis)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Alhemo 100 mg/ml Subcutaneous Injection, Solution
NDC: 0169-2080
Labeler:
Novo Nordisk
Alhemo 100 mg/ml Subcutaneous Injection, Solution
NDC: 0169-2081
Labeler:
Novo Nordisk
Alhemo 40 mg/ml Subcutaneous Injection, Solution
NDC: 0169-2084
Labeler:
Novo Nordisk